These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6382162)

  • 21. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism.
    Hirsh J; Siragusa S; Cosmi B; Ginsberg JS
    Thromb Haemost; 1995 Jul; 74(1):360-3. PubMed ID: 8578485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Old and new heparins.
    Cosmi B; Palareti G
    Thromb Res; 2012 Mar; 129(3):388-91. PubMed ID: 22137740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heparin therapy in pregnant women].
    Schleich JM; Laurent M; Almange C
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1291-300. PubMed ID: 11794972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The new heparins].
    Samama M
    Presse Med; 1986 Sep; 15(32):1631-5. PubMed ID: 2949211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse effects of heparin.
    Alban S
    Handb Exp Pharmacol; 2012; (207):211-63. PubMed ID: 22566227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heparins of different molecular weights: biological activity and hemorrhagic risk].
    Cofrancesco E; Pogliani EM
    Recenti Prog Med; 1987; 78(7-8):328-31. PubMed ID: 3321255
    [No Abstract]   [Full Text] [Related]  

  • 33. [Spinal anesthesia and prevention of thrombosis by heparin].
    Louville Y; Cazalaà JB
    Agressologie; 1990 Mar; 31(3):160-3. PubMed ID: 2240408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction.
    Ockelford PA; Carter CJ; Cerskus A; Smith CA; Hirsh J
    Thromb Res; 1982 Sep; 27(6):679-90. PubMed ID: 7179209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of low molecular weight heparin.
    Thomas DP
    Thromb Haemost; 1986 Dec; 56(3):241-2. PubMed ID: 3563958
    [No Abstract]   [Full Text] [Related]  

  • 36. Heparin: what is it? How does it work?
    Schwartz BS
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI12-5. PubMed ID: 2191809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemorrhagic complications of preventive anticoagulant therapy in surgery].
    Chapuis Y
    Helv Chir Acta; 1983 May; 50(1-2):173-86. PubMed ID: 6192109
    [No Abstract]   [Full Text] [Related]  

  • 38. Chance favors the prepared mind: the association between heparin-induced thrombocytopenia and bilateral adrenal hemorrhage.
    Namias N
    Crit Care Med; 2011 Apr; 39(4):912-3. PubMed ID: 21613853
    [No Abstract]   [Full Text] [Related]  

  • 39. The new understanding of the drug heparin.
    Jaques LB
    Chest; 1985 Nov; 88(5):751-4. PubMed ID: 2414075
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug prophylaxis in atherosclerosis.
    Jaques LB
    Artery; 1987; 14(4):209-15. PubMed ID: 2441684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.